Naoki Kunugita Selected Research

Multiple Chemical Sensitivity (Idiopathic Environmental Intolerance)

1/2007	Effect of long-term exposure to low-level toluene on airway inflammatory response in mice.
3/2005	Hypothalamo-pituitary-adrenal gland axis in mice inhaling toluene prior to low-level long-term exposure to formaldehyde.
9/2004	[Exposure to formaldehyde during an anatomy dissecting course].
6/2003	[Formaldehyde exposure and multiple chemical sensitivity].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Kunugita Research Topics

Disease

7	Neoplasms (Cancer) 11/2018 - 05/2004
5	Genomic Instability 03/2017 - 09/2013
4	Multiple Chemical Sensitivity (Idiopathic Environmental Intolerance) 01/2007 - 06/2003
3	Tobacco Use Disorder (Nicotine Dependence) 01/2020 - 01/2015
3	Burns 01/2018 - 04/2016
2	Inflammation (Inflammations) 07/2016 - 04/2004
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2016 - 07/2002
2	Hypersensitivity (Allergy) 01/2010 - 01/2010
2	Carcinoma (Carcinomatosis) 01/2003 - 10/2002
1	Wounds and Injuries (Trauma) 01/2022
1	Radiation Injuries (Radiation Sickness) 01/2019
1	Abdominal Obesity 09/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 07/2016
1	Obesity 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Diabetes Complications 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Hyperthermia 01/2015
1	Type 2 Diabetes Mellitus (MODY) 10/2014
1	Thymoma (Thymic Carcinoma) 01/2014
1	Immune System Diseases (Immune Disorders) 01/2013
1	Pneumonia (Pneumonitis) 10/2011
1	Memory Disorders (Memory Loss) 12/2010
1	Astrocytoma (Pilocytic Astrocytoma) 04/2009
1	Lymphoma (Lymphomas) 10/2007
1	Sick Building Syndrome 07/2004
1	Medically Unexplained Symptoms 06/2003

Drug/Important Bio-Agent (IBA)

5	Formaldehyde (Formol)FDA Link 03/2005 - 06/2003
4	SmokeIBA 04/2018 - 05/2012
4	Cyclin D1IBA 06/2016 - 09/2013
3	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 08/2014
3	Volatile Organic CompoundsIBA 01/2013 - 01/2007
3	TolueneIBA 12/2010 - 03/2005
2	Nicotine FDA Link 01/2020 - 04/2016
2	Particulate MatterIBA 07/2016 - 07/2002
2	Messenger RNA (mRNA)IBA 01/2010 - 04/2009
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	AmmoniaIBA 04/2018
1	AerosolsIBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 03/2017
1	AntioxidantsIBA 03/2017
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2016
1	oxidized low density lipoproteinIBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	LDL CholesterolIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2014
1	CarcinogensIBA 05/2012
1	NitrosaminesIBA 05/2012
1	FullerenesIBA 10/2011
1	Nerve Growth Factor (NGF)IBA 01/2010
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2007
1	OvalbuminIBA 07/2004
1	aluminum sulfate (alum)IBA 07/2004
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2004
1	Formaldehyde poisoningIBA 06/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	sodium arsenite (sodium metaarsenite)IBA 10/2002

Therapy/Procedure

1	Oral Administration 01/2019
1	Glycemic Control 01/2016
1	Hyperbaric Oxygenation 01/2015
1	Radiotherapy 08/2014